AbCellera Biologics (ABCL) EPS (Basic): 2019-2024
Historic EPS (Basic) for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to -$0.55.
- AbCellera Biologics' EPS (Basic) fell 70.00% to -$0.17 in Q4 2023 from the same period last year, while for Dec 2023 it was -$0.52, marking a year-over-year decrease of 192.86%. This contributed to the annual value of -$0.55 for FY2024, which is 7.84% down from last year.
- AbCellera Biologics' EPS (Basic) amounted to -$0.55 in FY2024, which was down 7.84% from -$0.51 recorded in FY2023.
- In the past 5 years, AbCellera Biologics' EPS (Basic) registered a high of $0.56 during FY2021, and its lowest value of -$0.55 during FY2024.
- For the 3-year period, AbCellera Biologics' EPS (Basic) averaged around -$0.17, with its median value being -$0.51 (2023).
- As far as peak fluctuations go, AbCellera Biologics' EPS (Basic) soared by 5,400.00% in 2020, and later tumbled by 191.07% in 2023.
- Over the past 5 years, AbCellera Biologics' EPS (Basic) (Yearly) stood at $0.53 in 2020, then rose by 5.66% to $0.56 in 2021, then remained steady at $0.56 in 2022, then tumbled by 191.07% to -$0.51 in 2023, then fell by 7.84% to -$0.55 in 2024.